NEU 5.77% $13.38 neuren pharmaceuticals limited

Here:Sell-siders say Biogen may seek acquisitions after...

  1. 258 Posts.
    lightbulb Created with Sketch. 12
    Here:

    Sell-siders say Biogen may seek acquisitions after aducanumab fail https://seekingalpha.com/news/3444897?source=ansh $BIIB, $BHVN, $NBIX, $ALDR, $SAGE, $ACAD, $GWPH, $SRPT

    they say about potential interest of Biogen also on Acadia.
    this should be a huge move for us.
    finger crossed.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.